人胃癌细胞系AGS外泌体miR-106a对腹膜间皮细胞系HMrSV5表型的影响

基础医学与临床 ›› 2021, Vol. 41 ›› Issue (11): 1564-1569.

人胃癌细胞系AGS外泌体miR-106a对腹膜间皮细胞系HMrSV5表型的影响

朱萌¹, 张宁², 陶伟^3*

1.宁夏医科大学基础医学院,宁夏银川 750004;
宁夏医科大学总医院 2.病理科; 3.消化内科,宁夏银川 750004

收稿日期:2020-11-10 修回日期:2021-04-30 发布日期:2021-10-27
通讯作者: *nyfytaowei@163.com
基金资助:
国家自然科学基金(81802416);宁夏自然科学基金(2020AAC02022);宁夏医科大学校级项目(XT2019007)

Effect of exosomes miR-106a derived from human gastric cancer cell line AGS on the phenotype of peritoneal mesothelial cell line HMrSV5

ZHU Meng¹, ZHANG Ning², TAO Wei^3*

1. Basic Medical College, Ningxia Medical University, Yinchuan 750004;
2. Department of Pathology; 3. Department of Gastroenterology, General Hospital,Ningxia Medical University, Yinchuan 750004, China

Received:2020-11-10 Revised:2021-04-30 Published:2021-10-27
Contact: *nyfytaowei@163.com

摘要/Abstract

摘要： 目的探讨人胃癌细胞系AGS外泌体及其包裹miR-106a对人腹膜间皮细胞系HMrSV5表型的影响。方法采用离心法分离AGS细胞来源外泌体,与HMrSV5细胞共培养,并加入外泌体分泌抑制剂GW4869。采用qPCR检测miR-106a表达量;EdU检测HMrSV5细胞增殖能力;流式细胞仪检测细胞凋亡。AGS细胞转染miR-106a mimic或inhibitor,共培养后利用Transwell小室法检测HMrSV5细胞迁移;Western blot检测Smad7、TIMP2、MMP2、MMP9、α-SMA蛋白表达。TGF-β处理HMrSV5细胞,共培养后Western blot检测Smad7、Smad2/3、p-Smad2/3蛋白表达。结果 AGS细胞高表达外泌体miR-106a(P＜0.01);与HMrSV5细胞共培养后明显抑制其增殖,促使早期凋亡率增加(P＜0.05)。转染miR-106a mimic后,AGS细胞源外泌体促进HMrSV5细胞迁移(P＜0.001),同时Smad7、TIMP2表达下降,MMP2、MMP9、α-SMA表达升高,阻断miR-106a传递后这一作用减弱。TGF-β处理后,Smad7表达减弱,Smad2/3、p-Smad2/3表达升高。结论 AGS细胞来源外泌体能够促进HMrSV5细胞凋亡、抑制增殖、增强迁移,可能与转运miR-106a靶向Smad7/TIMP2有关。

关键词: 胃癌, 间皮细胞, 外泌体, 微小RNA, Smad7

Abstract: Objective To investigate the effect of exosomes derived from human gastric cancer cell line AGS and miR-106a on the phenotype of peritoneal mesothelial cells line HMrSV5. Methods Exosomes from AGS cells were isolated and incubated with HMrSV5 cells. Then exosome secretion inhibitor GW4869 was added. miR-106a expression was detected by qPCR, HMrSV5 cells proliferation and apoptosis were detected by EdU and flow cytometry technology. After the AGS cells were transfected with miR-106a mimic or inhibitor, the migration of HMrSV5 cells was detected by Transwell assay, and the expression of Smad7, TIMP2, MMP2, MMP9 and α-SMA was detected by Western blot. After treatment with TGF-β, the expression of Smad7, Smad2/3 and p-Smad2/3 was detected by Western blot. Results The exosomes of AGS cells highly expressed miR-106a (P＜0.01), and incubation with HMrSV5 cells significantly inhibited its proliferation and promoted the early apoptosis rate(P＜0.05). After transfection of miR-106a mimic, the exosomes from AGS cells promoted the migration of HMrSV5 cells (P＜0.001). Meanwhile, the expression of Smad7 and TIMP2 was decreased, but the expression of MMP2, MMP9 and α-SMA was increased. After treatment with TGF-β, the expression of Smad7 decreased but the expression of Smad2/3 and p-Smad2/3 increased. Conclusions Exosomes derived from human gastric cancer AGS cells can promote apoptosis, inhibit proliferation and enhance migration of human peritoneal mesothelial HMrSV5 cells, which may be related to the transport of miR-106a targeting Smad7 and TIMP2.

Key words: gastric cancer, mesothelial cells, exosomes, microRNA, Smad7

中图分类号:

R735.2

朱萌, 张宁, 陶伟. 人胃癌细胞系AGS外泌体miR-106a对腹膜间皮细胞系HMrSV5表型的影响[J]. 基础医学与临床, 2021, 41(11): 1564-1569.

ZHU Meng, ZHANG Ning, TAO Wei. Effect of exosomes miR-106a derived from human gastric cancer cell line AGS on the phenotype of peritoneal mesothelial cell line HMrSV5[J]. Basic & Clinical Medicine, 2021, 41(11): 1564-1569.

参考文献

[1]Mutsaers SE, Prêle CM, Pengelly S, et al. Mesothelial cells and peritoneal homeostasis[J]. Fertil Steril, 2016, 106: 1018-1024.
[2]Zhu M, Zhang N, He S, et al. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7[J]. Cell Cycle, 2020, 19: 1200-1221.
[3]Zhu M, Zhang N, He S, et al. MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer[J]. FEBS Lett, 2014, 588: 600-607.
[4]Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367: eaau6977.doi:10.1126/science.aau6977.
[5]解修峰, 史志周. 肿瘤及其微环境源性外泌体miRNAs在致癌机制、肿瘤诊断和治疗中的研究进展[J]. 基础医学与临床, 2017, 37: 1326-1330.
[6]Lv ZD, Wang HB, Dong Q, et al. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo[J]. Mol Cell Biochem, 2013, 377: 177-185.
[7]Yan X, Liao H, Cheng M, et al. Smad7 protein interacts with receptor-regulated smads (R-Smads) to inhibit transforming growth factor-beta (TGF-beta)/Smad signaling[J]. J Biol Chem, 2016, 291: 382-392.
[8]Xu F, Liu C, Zhou D, et al. TGF-β/SMAD pathway and its regulation in hepatic fibrosis[J]. J histochem cytochem, 2016, 64: 157-167.
[9]Rynne-Vidal A, Au-Yeung CL, Jimenez-Heffernan JA, et al. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer[J]. 2017, 242: 140-151.
[10]Katsuno Y, Qin J, Oses-Prieto J, et al. Arginine methylation of SMAD7 by PRMT1 in TGF-β-induced epithelial-mesenchymal transition and epithelial stem-cell generation[J]. J Biol Chem, 2018, 293: 13059-13072.
[11]Avădanei R, Căruntu ID, Amălinei C, et al. High variability in MMP2/TIMP2 and MMP9/TIMP1 expression in secondary liver tumors[J]. Rom J Morphol Embryol, 2013, 54: 479-485.
[12]Yáñez-Mó M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells[J]. N Engl J Med, 2003, 348: 403-413.

[1]	刘磊, 李世宝, 张好良. 沉默lnc-SLC2A12-10:1抑制人胃癌细胞系AGS增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(7): 1071-1076.
[2]	陈希, 庞海玉, 秦春迪, 郭元红, 杨爱明, 赖雅敏. 学习金字塔模型理论的短期半浸入式培训提高识别早期胃癌能力[J]. 基础医学与临床, 2022, 42(4): 696-700.
[3]	牛世伟, 苏韫, 龚红霞, 李婷婷, 曾元丁, 张晗, 聂蓬. 胃癌患者血清IL-1的升高和癌组织JAK2/STAT3信号通路的激活[J]. 基础医学与临床, 2022, 42(3): 401-405.
[4]	李英杰, 杨庭楷, 纪志刚, 文进. 外泌体在前列腺癌诊疗中的研究进展[J]. 基础医学与临床, 2022, 42(1): 163-167.
[5]	侯楠, 刘源, 高俊, 王晶. miR-141-3p通过靶向PDCD1抑制人胃癌细胞系AGS的迁移与侵袭[J]. 基础医学与临床, 2021, 41(9): 1297-1302.
[6]	张传西, 张宇, 郭莎莎, 厉菁, 袁义强, 王明杰. 血清miR-181b和miR-27a表达与颈动脉粥样硬化程度相关[J]. 基础医学与临床, 2021, 41(8): 1133-1138.
[7]	刘炼玲, 李勇. 下调脂滴包被蛋白2抑制人胃癌细胞系NCI-N87增殖[J]. 基础医学与临床, 2021, 41(7): 1013-1017.
[8]	苏鹏飞, 蒋林, 章盈婧, 郭博, 马志强, 周炜洵, 于健春. 综合治疗79岁进展期胃癌1例[J]. 基础医学与临床, 2021, 41(7): 1043-1046.
[9]	毛洪宾, 何明. miR-26a调控PTEN基因降低小鼠慢性淋巴白血病细胞的耐药性[J]. 基础医学与临床, 2021, 41(6): 871-875.
[10]	杨旭东, 于红亮, 李静, 赵春华. 巨噬细胞J774A.1外泌体促进结直肠癌细胞系MC38和CT26的增殖和迁移[J]. 基础医学与临床, 2021, 41(6): 799-804.
[11]	马家玲, 高艳平. miR-183靶向Bnip3l对缺氧/复氧的小鼠海马神经元细胞线粒体自噬的影响[J]. 基础医学与临床, 2021, 41(5): 698-703.
[12]	赵晓龙, 代晓燕, 毛成毅, 肖华亮, 王东, 戴楠. 非小细胞肺癌患者血浆外泌体APE1的表达与铂类化疗敏感性相关[J]. 基础医学与临床, 2021, 41(2): 165-170.
[13]	杨宁波, 贾晓东, 寇耀. lncRNA RAB11B-AS1上调miR-628-3p抑制人胃癌细胞系增殖和迁移[J]. 基础医学与临床, 2021, 41(12): 1762-1766.
[14]	鲍美美, 徐雯, 王超, 王佳, 苗小芬. 石蒜碱抑制胃癌细胞系MGC-803增殖、迁移和侵袭[J]. 基础医学与临床, 2021, 41(12): 1767-1773.
[15]	杨屹立, 何学元, 潘新民, 马建勋. miR-205-5p抑制体外胃癌细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2020, 40(8): 1068-1075.